Hugel Obtains Sales Approval for Botulinum Toxin in China
[Asia Economy Reporter Minji Lee] Hugel announced on the 23rd that it has obtained sales approval for Botulinum Toxin Type A for Injection in China.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While All Eyes Were on Samsung and Hynix, This Company Surged 50% to New Highs in Four Days [Weekend Money]
- "Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- 6 Out of 10 Office Workers "Feel Gender Discrimination in Employment"... Women Perceive It Even More Strongly
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
The company stated, "Entering the major market of China will contribute to the expansion of overseas sales," and added, "We plan to launch the product locally within this year."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
